MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.

RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...

BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system.

Neuronetics (Nasdaq:STIM) announced today that it priced an underwritten public offering of common stock at approximately $18 ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

The FDA labeled a recall of integrated arterial catheters made by Medline Class I, the most serious kind of recall.

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...

Bausch + Lomb announced today that, after engagement with potential buyers, it has no immediate plan to sell. At the end of 2024, the company issued a statement outlining its plans for a potential ...

Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...

Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...

CVRx (Nasdaq:CVRX) shares took a hit today on fourth-quarter results that fell short of earnings per share expectations.

Newronika announced today that it received FDA investigational device exemption (IDE) for its deep brain stimulation (DBS) system.